{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:33:00Z","timestamp":1772155980086,"version":"3.50.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/nrl.0b013e31825bbf35","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T09:52:04Z","timestamp":1340790724000},"page":"179-183","source":"Crossref","is-referenced-by-count":16,"title":["Vitamin D and Multiple Sclerosis"],"prefix":"10.1097","volume":"18","author":[{"given":"Bianca","family":"Weinstock-Guttman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Karmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily Jung","family":"Henson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Halper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Riskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.22057","article-title":"Multiple sclerosis and viruses.","volume":"68","author":"Brahic","year":"2010","journal-title":"Ann Neurol"},{"key":"R2-1-20210211","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","article-title":"Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.","volume":"21","author":"Goldberg","year":"1986","journal-title":"Med Hypotheses"},{"key":"R3-1-20210211","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-9877(96)90002-X","article-title":"Multiple sclerosis: sunlight, diet, immunology and aetiology.","volume":"46","author":"Hutter","year":"1996","journal-title":"Med Hypotheses"},{"key":"R4-1-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.29.1.60","article-title":"Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation.","volume":"29","author":"Leibowitz","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-1-20210211","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology.","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol"},{"key":"R6-1-20210211","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"R7-1-20210211","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0447.1960.tb08674.x","article-title":"Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.","volume":"35","author":"Acheson","year":"1960","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R8-1-20210211","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0306-9877(97)90065-7","article-title":"Multiple sclerosis: a geographical hypothesis.","volume":"49","author":"Carlyle","year":"1997","journal-title":"Med Hypotheses"},{"key":"R9-1-20210211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis.","volume":"216","author":"Hayes","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"R10-1-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458508095920","article-title":"Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.","volume":"15","author":"Kragt","year":"2009","journal-title":"Mult Scler"},{"key":"R11-1-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00312546","article-title":"Geography in multiple sclerosis.","volume":"215","author":"Kurtzke","year":"1977","journal-title":"J Neurol"},{"key":"R12-1-20210211","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment.","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R13-1-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis.","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"R14-1-20210211","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322512","article-title":"Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis.","volume":"36","author":"McDowell","year":"2011","journal-title":"Neuroepidemiology"},{"key":"R15-1-20210211","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination.","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"R17-1-20210211","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets.","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Invest"},{"key":"R18-1-20210211","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/WNL.0b013e31821cccf5","article-title":"Vitamin D in African Americans with multiple sclerosis.","volume":"76","author":"Gelfand","year":"2011","journal-title":"Neurology"},{"key":"R20-1-20210211","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands.","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"key":"R21-1-20210211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","article-title":"Vitamin D as an immune modulator in multiple sclerosis, a review.","volume":"194","author":"Smolders","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R22-1-20210211","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.","volume":"87","author":"Lemire","year":"1991","journal-title":"J Clin Invest"},{"key":"R23-1-20210211","doi-asserted-by":"crossref","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D suppresses Th17 cytokine production by inducing CEBP homologous protein (CHOP) expression.","volume":"285","author":"Chang","year":"2010","journal-title":"J Biol Chem"},{"key":"R24-1-20210211","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00396-X","article-title":"Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.","volume":"134","author":"Mahon","year":"2003","journal-title":"J Neuroimmunol"},{"key":"R25-1-20210211","doi-asserted-by":"crossref","first-page":"e6635","DOI":"10.1371\/journal.pone.0006635","article-title":"Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.","volume":"4","author":"Smolders","year":"2009","journal-title":"PLoS One"},{"key":"R26-1-20210211","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22043","article-title":"Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.","volume":"68","author":"Simpson","year":"2010","journal-title":"Ann Neurol"},{"key":"R27-1-20210211","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21972","article-title":"Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.","volume":"67","author":"Mowry","year":"2010","journal-title":"Ann Neurol"},{"issue":"pt 5","key":"R28-1-20210211","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","article-title":"Immunomodulatory effects of vitamin D in multiple sclerosis.","volume":"132","author":"Correale","year":"2009","journal-title":"Brain"},{"key":"R29-1-20210211","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","article-title":"25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.","volume":"11","author":"Soilu-Hanninen","year":"2005","journal-title":"Mult Scler"},{"key":"R30-1-20210211","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-006-0315-8","article-title":"Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.","volume":"254","author":"van der Mei","year":"2007","journal-title":"J Neurol"},{"key":"R31-1-20210211","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458508094399","article-title":"Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.","volume":"14","author":"Smolders","year":"2008","journal-title":"Mult Scler"},{"key":"R32-1-20210211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2010.227942","article-title":"Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.","volume":"82","author":"Weinstock-Guttman","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R33-1-20210211","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","article-title":"Safety of vitamin D3 in adults with multiple sclerosis.","volume":"86","author":"Kimball","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R34-1-20210211","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"R35-1-20210211","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans.","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-1-20210211","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-1-20210211","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/84.4.694","article-title":"The case against ergocalciferol (vitamin D2) as a vitamin supplement.","volume":"84","author":"Houghton","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R38-1-20210211","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"R39-1-20210211","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R40-1-20210211","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase III dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"key":"R41-1-20210211","first-page":"607","article-title":"Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention.","volume":"31","author":"Garland","year":"2011","journal-title":"Anticancer Res"},{"key":"R42-1-20210211","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1200\/JCO.2005.10.462","article-title":"Epidemiology of lung cancer: looking to the future.","volume":"23","author":"Alberg","year":"2005","journal-title":"J Clin Oncol"},{"key":"R43-1-20210211","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/ijc.22807","article-title":"Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC).","volume":"121","author":"Linseisen","year":"2007","journal-title":"Int J Cancer"},{"key":"R46-1-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/1055-9965.EPI-038-3","article-title":"Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies.","volume":"13","author":"Mannisto","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"suppl","key":"R47-1-20210211","doi-asserted-by":"crossref","first-page":"1427S","DOI":"10.1093\/ajcn\/62.6.1427S","article-title":"Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study.","volume":"62","author":"Albanes","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"R48-1-20210211","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/88.21.1550","article-title":"Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.","volume":"88","author":"Omenn","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R49-1-20210211","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/aje\/kwn409","article-title":"Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study.","volume":"169","author":"Satia","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R50-1-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R51-1-20210211","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2011.04.013","article-title":"Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial.","volume":"311","author":"Smolders","year":"2011","journal-title":"J Neurol Sci"},{"key":"R52-1-20210211","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","article-title":"Risk of bone loss in men with multiple sclerosis.","volume":"10","author":"Weinstock-Guttman","year":"2004","journal-title":"Mult Scler"},{"key":"R53-1-20210211","first-page":"CD007470","article-title":"Vitamin D supplementation for prevention of mortality in adults.","volume":"7","author":"Bjelakovic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R54-1-20210211","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/14656566.9.1.107","article-title":"Diagnosis and treatment of vitamin D deficiency.","volume":"9","author":"Cannell","year":"2008","journal-title":"Expert Opin Pharmacother"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-201207000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:09:28Z","timestamp":1714090168000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201207000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31825bbf35","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718010233.793476628","asserted-by":"object"}]},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}